ED50: 0.0149 ng/ml, as determined by the dose-dependent inhibition of IL-4-induced proliferation of HT-2 cells, corresponding to a specific activity of 6.7x107U/mg.
Purity
>95% as determined by SDS-PAGE.
Product Form
Lyophilized
Concentration
Reconstitution dependent.
Formulation
Lyophilized from a solution containing 0.1% TFA and 1:20 Trehalose.
Storage
Shipped at ambient temperature. Lyophilized: Short term (3 weeks) store at 25°C. Long term store desiccated below -18°C. Reconstituted: Short term (2-7 days) store at 4°C. Long term store below -18°C, it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid freeze/thaw cycles.
